Pulmonary hypertension: treprostinil safe and effective in the long term?

被引：0
|
作者：
Simon, Annika
机构：
来源：
PNEUMOLOGIE | 2024年 / 78卷 / 03期
关键词：
D O I：
10.1055/a-2196-8522
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Nachdem eine Therapie mit inhaliertem Trepostinil in der INCREASE-Studie mit Betroffenen einer pulmonalen Hypertonie mit interstitieller Lungenerkrankung uber 16 Wochen als sicher und wirksam bewertet werden konnte, stellt sich die Frage nach entsprechenden Effekten im Rahmen einer Langzeittherapie. Waxman et al. sind dieser Frage nachgegangen und haben eine offene Verlangerung dieser Studie initiiert.
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Long Term Safety Of Inhaled Treprostinil In Patients With Pulmonary Arterial Hypertension (pah): Interim Analysis Of The Aspire Registry
    Zamanian, R. T.
    Levine, D. J.
    Rosenzweig, E. B.
    Alnuaimat, H.
    DeMarco, T.
    Bourge, R. C.
    Peterson, L.
    Arneson, C.
    Imm, J. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [32] The Role of Treprostinil in the Management of Pulmonary Hypertension
    Nika Skoro-Sajer
    Irene Lang
    American Journal of Cardiovascular Drugs, 2008, 8 : 213 - 217
  • [33] Inhaled treprostinil sodium for pulmonary hypertension
    Gupta, Vedant
    Krasuski, Richard A.
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (03): : 283 - 291
  • [34] Treprostinil for the treatment of pulmonary arterial hypertension
    Torres, Fernando
    Rubin, Lewis J.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2013, 11 (01) : 13 - 25
  • [35] Treprostinil therapy for pulmonary artery hypertension
    Horn, EM
    Barst, RJ
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (11) : 1615 - 1622
  • [36] Treprostinil (remodulin) for pulmonary arterial hypertension
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2002, 44 (1139): : 80 - 82
  • [37] The role of treprostinil in the management of pulmonary hypertension
    Skoro-Sajer, Nika
    Lang, Irene
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2008, 8 (04) : 213 - 217
  • [38] Inhaled treprostinil and pulmonary arterial hypertension
    Nadler, Samuel T.
    Edelman, Jeffrey D.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2010, 6 : 1115 - 1124
  • [39] Right ventricular afterload predicts long-term transition from parenteral to oral treprostinil in pulmonary arterial hypertension
    Maestas, Travis
    Hansen, Lillian M.
    Vanderpool, Rebecca R.
    Desai, Ankit A.
    Airhart, Sophia
    Knapp, Shannon M.
    Cohen, Adam
    Feldman, Jeremy
    Rischard, Franz P.
    PULMONARY CIRCULATION, 2018, 8 (04)
  • [40] Strategies to EXPEDITE the Time to Effective Dosing of Oral Treprostinil in Patients with Pulmonary Arterial Hypertension
    Miller, C. E.
    Franco, V.
    Zolty, R.
    Kingrey, J. F.
    Oudiz, R. J.
    Elwing, J. M.
    Huston, J. H.
    Melendres-Groves, L.
    Tarver, J.
    Ravichandran, A.
    Shen, E.
    Broderick, M.
    Balasubramanian, V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
12345